Skip to main content
Caplight Logo









Genomate Health

Genomate Health

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://genomate.health

Last Round

VC Round

May 5, 2025

Total Funding Raised

$2.25M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Genomate Health operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a VC Round in May 2025.

Genomate Health is a digital health company that provides a clinically validated, AI-powered computational platform to help oncologists make personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Genomate Health Comparables

Compare Genomate Health with similar companies based on industry and business-model similarity.

Genomate Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CureMatch
89%
Clarified Precision Medicine
84%
GenomOncology
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Genomate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 5, 2025
VC RoundFeb 11, 2025
SeedApr 16, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Istvan Petak

Founder and Chief Scientific Officer

Founding Team

Nabil Hafez

Chief Executive Officer

Executive Team

Peter Filotas

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Genomate Health Investors

Notable investors and investment history

Genomate Health investors
InvestorRounds
Plug and Play Tech CenterVC Round
Mayo Clinic PlatformSeed
STRT HoldingVC Round
OktogonVC Round
Accessio Equity PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 346% MoM, reaching 10.8K.

  • Jul 25, 2026

    Monthly visitors increased 33% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withOct 27, 2026

    Genomate Health, Inc. and VivaMed BioPharma, Inc. form a strategic partnership in Massachusetts on Oct 27th '26 to rescue and repurpose oncology drugs using AI and clinical data.

  • receives_awardOct 20, 2026

    Genomate Health, Inc. receives the BE100 Health & Wellness award from Blue Earth at its summit in the United Kingdom on Oct 14th-16th '26 and is selected for a minimum GBP 100,000 investment through BE100 Fund II.

  • recognized_asOct 7, 2026

    GenomeWeb names Genomate Health, Inc. the winner of its Best Places to Work 26–50 employee category for the second consecutive year in Massachusetts on Oct 15th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Genomate Health Filings

Explore SEC and related filing metadata, where available.

Genomate Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Genomate Health's valuation, stock price, and market status.

Is Genomate Health a public or private company?

Genomate Health is a private company.

What is the current stock price of Genomate Health?

Genomate Health is a private company, so its shares have no public market price. Caplight tracks Genomate Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genomate Health worth (valuation)?

Valuation information for Genomate Health is not publicly available.

Can I buy Genomate Health stock?

Genomate Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genomate Health's last funding round?

Genomate Health's most recent funding round was VC Round on May 5, 2025.

Who are the main investors in Genomate Health?

Key investors in Genomate Health include Plug and Play Tech Center, Mayo Clinic Platform, STRT Holding, Oktogon, Accessio Equity Partners.

Will Genomate Health IPO soon?

No public IPO plans have been announced for Genomate Health.

How can I track Genomate Health secondary market activity?

Caplight tracks bids, offers, and trades in Genomate Health's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range27
Year Founded2022
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?